MicroPort Scientific Flags H1 Profit, Revenue Decline in MicroPort Endovascular Medtech; Shares Fall 1%
MT Newswires Live
Jul 15
MicroPort Scientific (HKG:0853) said it expects Shanghai MicroPort Endovascular MedTech (Group) to report a year-over-year decrease in H1 profit and revenue, according to a Hong Kong bourse filing Monday.
Shares of the medical device company fell over 1% in afternoon trade Tuesday.
MicroPort Scientific owns 40% of EV Medtech and the business' results are consolidated with the financial statements of the company.
MicroPort Endovascular Medtech is expected to report 303.5 million yuan to 361.1 million yuan in profit for the first half of the year, down 11% to 25% year over year.
Revenue for the period is expected to be 708.5 million yuan to 787.2 million yuan, up to 10% lower when compared to a year prior.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.